As of 9:30 AM on the 21st, Seegene is trading at 261,000 KRW, down 1.14% from the previous day. The trading volume is 133,600 shares, which is about 17.84% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.
On September 18, Yoon Chang-min, a researcher at Shinhan Financial Investment, stated, "Compared to the early spread of COVID-19, the supply and demand of diagnostic kits have entered a stabilization phase. Seegene has competitiveness in all areas including technology, distribution channels, and production capacity compared to other companies. Unlike other companies with high earnings volatility, it maintains steady earnings growth, showing differentiation." He set Seegene's target price at 350,000 KRW.
Over the past five days, individual investors have net sold 45,330 shares of Seegene, while foreigners and institutions have net sold 27 shares and net bought 87,295 shares, respectively.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
